CLINICAL IMPLEMENTATION OF A NOVEL HIGH-THROUGHPUT SCREEN OF PRIMARY LEUKEMIA CELLS TO PERSONALIZE THERAPY FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

被引：0
|
作者：
Frattini, M. [1 ]
Shum, D. [1 ]
Heaney, M. [1 ]
Brentjens, R. [1 ]
Maslak, P. [1 ]
Jurcic, J. [1 ]
Djaballah, H. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0048
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [21] Efficacy of Single-Agent Decitabine in Relapsed and Primary Refractory (rel/ref) Acute Myeloid Leukemia (AML)
    Hantel, Andrew
    Khan, Niloufer
    Larson, Richard A.
    Godley, Lucy A.
    Thirman, Michael J.
    Artz, Andrew
    Odenike, Olatoyosi
    Liu, Hongtao
    Churpek, Jane E.
    King, Darren
    Rich, Elizabeth
    Choi, Kwang Jin
    Knoebel, Randall W.
    Stock, Wendy
    BLOOD, 2015, 126 (23)
  • [22] FLAG-IDA as frontline induction or salvage therapy for patients with high risk and/or relapsed or refractory acute myeloid leukemia (AML)
    Bhella, Sita
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Minden, Mark D.
    Schimmer, Aaron David
    Gupta, Vikas
    Seftel, Matthew D.
    Alam, Naheed
    Lutynski, Andrzej
    Rydlewski, Anna
    Rostom, Amr
    Yee, Karen W. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients
    Tyner, Jeffrey W.
    Erickson, Heidi
    Deininger, Michael W. N.
    Willis, Stephanie G.
    Eide, Christopher A.
    Levine, Ross L.
    Heinrich, Michael C.
    Gattermann, Norbert
    Gilliland, D. Gary
    Druker, Brian J.
    Loriaux, Marc M.
    BLOOD, 2009, 113 (08) : 1749 - 1755
  • [24] Distinct Properties of Leukemia Stem Cells in Primary Refractory Acute Myeloid Leukemia
    Mendler, Jason H.
    Balys, Marlene
    Sivagnanalingam, Umayal
    Eberhardt, Allison
    Thorne, Korinne
    Ho, Tzu-Chieh
    LaMere, Mark W.
    Moore, Samuel
    McMurray, Helene
    Myers, Jason R.
    Ashton, John M.
    O'Dwyer, Kristen
    Liesveld, Jane L.
    Calvi, Laura M.
    Becker, Michael W.
    BLOOD, 2015, 126 (23)
  • [25] Novel Combination Therapy of Venetoclax and Ruxolitinib in the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Borate, Uma
    Saultz, Jennifer N.
    Kaempf, Andy
    Minnier, Jessica
    Tognon, Cristina E.
    Kurtz, Stephen E.
    Eide, Christopher A.
    Patel, Prapti A.
    Madanat, Yazan F.
    Clement, Peter
    Avaylon, Sammantha
    Misra, Shikha
    Druker, Brian J.
    Tyner, Jeffrey W.
    BLOOD, 2021, 138
  • [26] Treatment of relapsed/refractory acute myeloid leukemia (AML) with thalidomide as a single agent: Clinical and biologic responses.
    Manson, SD
    Venugopal, P
    Gregory, SA
    Raza, A
    Sivaraman, S
    Preisler, H
    BLOOD, 2001, 98 (11) : 215B - 215B
  • [27] Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay
    Becker, Pamela S.
    Oehler, Vivian
    Estey, Elihu H.
    Martins, Timothy
    Perdue, Andrea
    David, Jodie
    Chien, Sylvia
    Hendrie, Paul C.
    Ostronoff, Fabiana
    Blau, C. Anthony
    BLOOD, 2014, 124 (21)
  • [28] A Comparative Analysis of the Immunoglobulin Repertoire in Leukemia Cells and B Cells in Chinese Acute Myeloid Leukemia by High-Throughput Sequencing
    Yan, Huige
    Wu, Lina
    Wang, Pingzhang
    Xia, Miaoran
    Shi, Zhan
    Huang, Xinmei
    Yin, Sha
    Jiang, Qian
    Yin, C. Cameron
    Zhao, Xiangyu
    Qiu, Xiaoyan
    BIOLOGY-BASEL, 2024, 13 (08):
  • [29] Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Zeidner, Joshua F.
    Vincent, Benjamin G.
    Ivanova, Anastasia
    Foster, Matthew
    Coombs, Catherine C.
    Jamieson, Katarzyna
    Van Deventer, Hendrik
    Scibilia, Richard
    Blanchard, Laura
    Frank, Cassiopeia
    Gallagher, Sean
    Matson, Melissa
    Pepin, Katherine
    Vaught, Lori
    Vogler, Nancy
    Gojo, Ivana
    Luznik, Leo
    Serody, Jonathan S.
    BLOOD, 2017, 130
  • [30] FLAG with Oral Fludarabine for Primary Refractory or Relapsed Acute Lymphoid or Myeloid Leukemia
    Demichelis, Roberta
    Crespo, Erick
    Perez, Fernando
    Valencia, Ubaldo
    Guzman, Patricia
    BLOOD, 2014, 124 (21)
12345